title: Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression.
abstract: The retinoblastoma (RB) and p16ink4a tumor suppressors are believed to function in a linear pathway that is functionally inactivated in a large fraction of human cancers. Recent studies have shown that RB plays a critical role in regulating S phase as a means for suppressing aberrant proliferation and controlling genome stability. Here, we demonstrate a novel role for p16ink4a in replication control that is distinct from that of RB. Specifically, p16ink4a disrupts prereplication complex assembly by inhibiting mini-chromosome maintenance (MCM) protein loading in G1, while RB was found to disrupt replication in S phase through attenuation of PCNA function. This influence of p16ink4a on the prereplication complex was dependent on the presence of RB and the downregulation of cyclin-dependent kinase (CDK) activity. Strikingly, the inhibition of CDK2 activity was not sufficient to prevent the loading of MCM proteins onto chromatin, which supports a model wherein the composite action of multiple G1 CDK complexes regulates prereplication complex assembly. Additionally, p16ink4a attenuated the levels of the assembly factors Cdt1 and Cdc6. The enforced expression of these two licensing factors was sufficient to restore the assembly of the prereplication complex yet failed to promote S-phase progression due to the continued absence of PCNA function. Combined, these data reveal that RB and p16ink4a function through distinct pathways to inhibit the replication machinery and provide evidence that stepwise regulation of CDK activity interfaces with the replication machinery at two discrete execution points.
authors.affiliation: Department of Cell Biology, Vontz Center for Molecular Studies, 3125 Eden Avenue, Cincinnati, OH 45267-0521, USA.
authors.forename: Wesley A
authors.initials: WA
authors.lastname: Braden
authors.forename: Jon M
authors.initials: JM
authors.lastname: Lenihan
authors.forename: Zhengdao
authors.initials: Z
authors.lastname: Lan
authors.forename: K Scott
authors.initials: KS
authors.lastname: Luce
authors.forename: William
authors.initials: W
authors.lastname: Zagorski
authors.forename: Emily
authors.initials: E
authors.lastname: Bosco
authors.forename: Michael F
authors.initials: MF
authors.lastname: Reed
authors.forename: Jeanette G
authors.initials: JG
authors.lastname: Cook
authors.forename: Erik S
authors.initials: ES
authors.lastname: Knudsen
mesh_terms: D018797:Cell Cycle Proteins / Q000235:genetics; D045744:Cell Line, Tumor; D002875:Chromosomes / Q000235:genetics; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000378:metabolism; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D004261:DNA Replication / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D009687:Nuclear Proteins / Q000235:genetics; D011485:Protein Binding; D012175:Retinoblastoma / Q000235:genetics* / Q000378:metabolism*; D016196:S Phase; D015398:Signal Transduction
chemical_list: C103706:CDC6 protein, human; D018797:Cell Cycle Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D009687:Nuclear Proteins; D018844:Cyclin-Dependent Kinases